Dark
Light
System
Institutional Investment Manager
DAFNA Capital Management LLC
DAFNA Capital Management LLC (CIK: 0001389933), located at 10990 Wilshire Boulevard, Los Angeles, CA. Institutional holdings reported to the SEC.

Institutional Holdings (2015Q1)
Portfolio Summary: 71 holdings with a total value of $130,246,000.
#
Name
Shares
Value ($)
%
Options
Notes
1 PHARMACYCLICS INC 71,628 18,333,000 14.08% SH
2 ATRICURE INC 637,431 13,061,000 10.03% SH
3 AUSPEX PHARMACEUTICALS INC 120,500 12,083,000 9.28% SH
4 NXSTAGE MED INC COM 366,554 6,341,000 4.87% SH
5 DISCOVERY LABORATORIES INC N 4,829,874 5,748,000 4.41% SH
6 AERIE PHARMACEUTICALS INC 160,242 5,022,000 3.86% SH
7 RIGEL PHARMACEUTICAL INC 1,109,740 3,962,000 3.04% SH
8 INSULET CORPORATION 106,018 3,536,000 2.71% SH
9 DERMA SCIENCES INC COM PAR .01 373,918 3,167,000 2.43% SH
10 PROTALIX BIOTHERAPEUTICS INC 4,000,000 3,060,000 2.35% PRN
11 Stereotaxis Inc 1,372,862 2,815,000 2.16% SH
12 THRESHOLD PHARMACEUTICAL INC 625,558 2,540,000 1.95% SH
13 INSULET CORP 2 06/15/2019 2,407,000 2,419,000 1.86% PRN
14 ACHILLION PHARMACEUTICALS INC COM 241,600 2,382,000 1.83% SH
15 PROTALIX BIOTHERAPEUTICS INC 1,230,789 2,191,000 1.68% SH
16 APPLIED GENETIC TECHNOL CORP 109,323 2,185,000 1.68%
17 MASIMO CORP COM 66,000 2,177,000 1.67% SH
18 BIOTELEMETRY INC COM 235,645 2,085,000 1.60% SH
19 Otonomy Inc 50,000 1,768,000 1.36%
20 CLOVIS ONCOLOGY INC 23,400 1,737,000 1.33% SH
21 NOVADAQ TECHNOLOGIES INC 101,841 1,654,000 1.27% SH
22 ZS PHARMA INC 39,100 1,645,000 1.26%
23 Ascendis Pharma 93,541 1,623,000 1.25%
24 Neothetics Inc 186,807 1,534,000 1.18% SH
25 BIOCRYST PHARMACEUTICALS 166,656 1,505,000 1.16% SH
26 ESSA Pharma 250,000 1,422,000 1.09%
27 SPECTRANETICS CORP 39,812 1,384,000 1.06% SH
28 TARGACEPT INC 465,293 1,382,000 1.06% SH
29 ZOGENIX INC 853,700 1,170,000 0.90%
30 SYNERON MEDICAL LTD ORD SHS 90,947 1,126,000 0.86% SH
31 CYTRX CORP 300,813 1,014,000 0.78% SH
32 BLUEBIRD BIO INCORPORATED 8,000 966,000 0.74% SH
33 TANDEM DIABETES CARE INC 76,340 963,000 0.74%
34 JOHNSON & JOHNSON 9,400 946,000 0.73% SH
35 CARDICA INC 1,486,004 936,000 0.72% SH
36 NUVASIVE INC 760,000 935,000 0.72% PRN
37 ENCISION INC 1,062,500 829,000 0.64% SH
38 XENOPORT INC 116,259 828,000 0.64% SH
39 Exactech Inc 31,636 811,000 0.62% SH
40 UNIQURE NV 30,000 730,000 0.56% SH
41 Curis, Inc 299,800 720,000 0.55% SH
42 Cynapsus Therapeutics Inc 717,200 687,000 0.53%
43 CAREDX INC 123,883 687,000 0.53% SH
44 CHECK POINT SOFTWARE 110,000 605,000 0.46%
45 Cogentix Medical Inc 353,181 593,000 0.46%
46 INTERCEPT PHARMACEUTICAL 2,000 564,000 0.43% SH
47 CYNAPSUS THERAPEUTICS INC 543,927 521,000 0.40% SH
48 MINERVA NEUROSCIENCES INC COM 101,317 507,000 0.39%
49 KERYX BIOPHARMACEUTICALS INCORPORATED 34,800 443,000 0.34% SH
50 RTI SURGICAL HOLDINGS INC COM 85,918 424,000 0.33% SH
Page 1 of 2

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001389933-15-000013, filed 2015.05.15).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.